Table 2 Association between POLA2+1747 GG/GA interaction pairs and the overall survival time of 43 NSCLC patients receiving gemcitabine, based on the corresponding p-value.
From: Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients
No | Genotype Interaction Pairs | Significance Level (P value) | |
|---|---|---|---|
1 | POLA2+1747 GG/GA | SLC28A2+65 CC | 0.0004 |
2 | POLA2+1747 GG/GA | SLC28A2+225 CC | 0.0010 |
3 | POLA2+1747 GG/GA | RRM1(-756) TT | 0.0627 |
4 | POLA2+1747 GG/GA | SLC28A3+338 AA | 0.2859 |
5 | POLA2+1747 GG/GA | RRM1(-269) CC | 0.3767 |